EcoDrugPlus

Ensembl ID : ENSTNIG00000004492
Gene Symbol: -
1 Cross references
178 Possible Orthologues:

Ensembl ID : ENSTNIG00000004516
Gene Symbol: -
1 Cross references
358 Possible Orthologues:

Ensembl ID : ENSTNIG00000004521
Gene Symbol: -
2 Cross references
155 Possible Orthologues:

Ensembl ID : ENSTNIG00000004709
Gene Symbol: SIGMAR1
2 Cross references
163 Possible Orthologues:

Ensembl ID : ENSTNIG00000004712
Gene Symbol: SIGMAR1
2 Cross references
203 Possible Orthologues:

Ensembl ID : ENSTNIG00000004858
Gene Symbol: -
1 Cross references
173 Possible Orthologues:

Ensembl ID : ENSTNIG00000004953
Gene Symbol: -
1 Cross references
246 Possible Orthologues:

Ensembl ID : ENSTNIG00000005015
Gene Symbol: -
1 Cross references
195 Possible Orthologues:

Ensembl ID : ENSTNIG00000005195
Gene Symbol: -
1 Cross references
210 Possible Orthologues:

Ensembl ID : ENSTNIG00000005196
Gene Symbol: -
1 Cross references
210 Possible Orthologues:

Ensembl ID : ENSTNIG00000005206
Gene Symbol: -
1 Cross references
185 Possible Orthologues:

Ensembl ID : ENSTNIG00000005374
Gene Symbol: -
1 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).